Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2018

01-06-2018 | Research Article

Quality pharmacy services and key performance indicators in Polish NICUs: a Delphi approach

Authors: Natalia Krzyżaniak, Iga Pawłowska, Beata Bajorek

Published in: International Journal of Clinical Pharmacy | Issue 3/2018

Login to get access

Abstract

Background Currently, there is no literature describing what a quality level of practice entails in Polish neonatal intensive care units (NICUs), nor are there any means of currently measuring the quality of pharmaceutical care provided to NICU patients. Objective To identify a set of essential pharmacist roles and pharmacy-relevant key performance indicators (KPI’s) suitable for Polish neonatal intensive units (NICUs). Setting Polish hospital pharmacies and NICUs. Method Using a modified Delphi technique, potential KPI’s structured along Donabedian’s domains as well as pharmacy services were presented to an expert panel of stakeholders. Two online, consecutive Delphi rounds, were completed by panellists between August and September 2017. Main outcome measure To identify the minimum level of pharmacy services that should be consistently provided to NICU patients. Results A total of 16 panellists contributed to the expert panel. Overall, consensus of 75% was reached for 23 indicators and for 28 roles. When considering pharmacy services for the NICU, the experts were found to highly value traditional pharmacy roles, such as dispensing and extemporaneous compounding, however, they were still eager for roles in the other domains, such as educational and clinical services, to be listed as essential for NICU practice. Panellists were found to positively value the list of indicators presented, and excluded only 9 out of the total list. Conclusion There is a need for future research to establish a minimum standard of practice for Polish pharmacists to encourage the progression and standardisation of hospital pharmacy services to meet the level of practice seen in NICUs worldwide.
Literature
1.
go back to reference Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513–21.CrossRefPubMedPubMedCentral Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513–21.CrossRefPubMedPubMedCentral
2.
go back to reference Gilbar P, Stefaniuk K. The role of the pharmacist in palliative care: results of a survey conducted in Australia and Canada. J Palliat Care. 2002;18(4):287–92.PubMed Gilbar P, Stefaniuk K. The role of the pharmacist in palliative care: results of a survey conducted in Australia and Canada. J Palliat Care. 2002;18(4):287–92.PubMed
3.
go back to reference Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacother J Hum Pharmacol Drug Therapy. 2007;27(4):481–93.CrossRef Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacother J Hum Pharmacol Drug Therapy. 2007;27(4):481–93.CrossRef
4.
go back to reference Cotter S, Barber N, McKee M. Survey of clinical pharmacy services in United Kingdom National Health Service hospitals. Am J Health Syst Pharm. 1994;51(21):2676–84. Cotter S, Barber N, McKee M. Survey of clinical pharmacy services in United Kingdom National Health Service hospitals. Am J Health Syst Pharm. 1994;51(21):2676–84.
5.
go back to reference Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care. 2005;14(3):207–11.CrossRefPubMedPubMedCentral Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care. 2005;14(3):207–11.CrossRefPubMedPubMedCentral
6.
go back to reference Łasocha P, Merks P, Olszewska A. Farmacja szpitalna i kliniczna w Wielkiej Brytanii (Hospital and Clinical Pharmacy in the United Kingdom). Farmacja Polska. 2013;69(9):527–30. Łasocha P, Merks P, Olszewska A. Farmacja szpitalna i kliniczna w Wielkiej Brytanii (Hospital and Clinical Pharmacy in the United Kingdom). Farmacja Polska. 2013;69(9):527–30.
7.
go back to reference Pawłowska I, Pawłowski L, Kocić I, Krzyżaniak N. Clinical and conventional pharmacy services in Polish hospitals: a national survey. Int J Clin Pharm. 2016;38(2):271–9.CrossRefPubMedPubMedCentral Pawłowska I, Pawłowski L, Kocić I, Krzyżaniak N. Clinical and conventional pharmacy services in Polish hospitals: a national survey. Int J Clin Pharm. 2016;38(2):271–9.CrossRefPubMedPubMedCentral
8.
go back to reference Piecuch A, Kozłowska-Wojciechowska M, Jaszewska E, Makarewicz-Wujec M. Farmaceuta kliniczny—odpowiedź na zmieniające się potrzeby społeczne (The Clinical Pharmacist—response to societal needs). Farm Pol. 2014;70(7):395–9. Piecuch A, Kozłowska-Wojciechowska M, Jaszewska E, Makarewicz-Wujec M. Farmaceuta kliniczny—odpowiedź na zmieniające się potrzeby społeczne (The Clinical Pharmacist—response to societal needs). Farm Pol. 2014;70(7):395–9.
10.
go back to reference da Silva NMM. The impact of pharmacist participation in a multidisciplinary team on an oncology ward compared with a ward clinical pharmacy service. Eur J Hosp Pharm Sci Pract. 2012;19(2):259–60. da Silva NMM. The impact of pharmacist participation in a multidisciplinary team on an oncology ward compared with a ward clinical pharmacy service. Eur J Hosp Pharm Sci Pract. 2012;19(2):259–60.
11.
go back to reference Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168(7):687–94.CrossRefPubMed Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168(7):687–94.CrossRefPubMed
12.
go back to reference Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–80.CrossRefPubMed Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–80.CrossRefPubMed
13.
14.
go back to reference Dice J, Burckart G, Woo J, Helms R. Standardized versus pharmacist-monitored individualized parenteral nutrition in low-birth-weight infants. Am J Health Syst Pharm. 1981;38(10):1487–9. Dice J, Burckart G, Woo J, Helms R. Standardized versus pharmacist-monitored individualized parenteral nutrition in low-birth-weight infants. Am J Health Syst Pharm. 1981;38(10):1487–9.
15.
go back to reference Dunkley M. Neonatal intensive care–an Australian survey of the pharmacist’s role. Aust J Hosp Pharm. 1991;21:104–8. Dunkley M. Neonatal intensive care–an Australian survey of the pharmacist’s role. Aust J Hosp Pharm. 1991;21:104–8.
16.
go back to reference Gray JE, Goldmann DA. Medication errors in the neonatal intensive care unit: special patients, unique issues. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F472–3.CrossRefPubMedPubMedCentral Gray JE, Goldmann DA. Medication errors in the neonatal intensive care unit: special patients, unique issues. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F472–3.CrossRefPubMedPubMedCentral
17.
go back to reference Simpson J, Lynch R, Grant J, Alroomi L. Reducing medication errors in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F480–2.CrossRefPubMedPubMedCentral Simpson J, Lynch R, Grant J, Alroomi L. Reducing medication errors in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2004;89(6):F480–2.CrossRefPubMedPubMedCentral
18.
go back to reference Stavroudis TA, Miller MR, Lehmann CU. Medication errors in neonates. Clin Perinatol. 2008;35(1):141–61.CrossRefPubMed Stavroudis TA, Miller MR, Lehmann CU. Medication errors in neonates. Clin Perinatol. 2008;35(1):141–61.CrossRefPubMed
20.
go back to reference Banks M, Board N, Curtis I, Davis E, Dunbar N, Jorm C. Developing a safety and quality framework for Australia. Darlinghurst: Australian Commission on Safety and Quality in Health Care; 2017. Banks M, Board N, Curtis I, Davis E, Dunbar N, Jorm C. Developing a safety and quality framework for Australia. Darlinghurst: Australian Commission on Safety and Quality in Health Care; 2017.
21.
go back to reference European Directorate for the Quality of Medicines and HealthCare (EDQM). Pharmaceutical Care—policies and practices for a safer, more responsible and cost-effective health system. Strasbourg: Directorate for the Quality of Medicines and HealthCare of the Council of Europe, 2012. European Directorate for the Quality of Medicines and HealthCare (EDQM). Pharmaceutical Care—policies and practices for a safer, more responsible and cost-effective health system. Strasbourg: Directorate for the Quality of Medicines and HealthCare of the Council of Europe, 2012.
22.
go back to reference Scobie S, Thomson R, McNeil JJ, Phillips PA. Measurement of the safety and quality of health care. Med J Aust. 2006;184(10):S51.PubMed Scobie S, Thomson R, McNeil JJ, Phillips PA. Measurement of the safety and quality of health care. Med J Aust. 2006;184(10):S51.PubMed
24.
go back to reference Krzyzaniak N, Bajorek B. Quality use of medicines in neonatal care: a review of measures of quality used to evaluate the appropriateness and rational use of medication within the NICU. Drugs Therapy Perspect. 2016;32(9):392–402.CrossRef Krzyzaniak N, Bajorek B. Quality use of medicines in neonatal care: a review of measures of quality used to evaluate the appropriateness and rational use of medication within the NICU. Drugs Therapy Perspect. 2016;32(9):392–402.CrossRef
25.
go back to reference Krzyżaniak N, Pawłowska I, Bajorek B. The role of the clinical pharmacist in the NICU: a cross-sectional survey of Australian and Polish pharmacy practice. Eur J Hosp Pharm. 2018:ejhpharm-2017-001432. Krzyżaniak N, Pawłowska I, Bajorek B. The role of the clinical pharmacist in the NICU: a cross-sectional survey of Australian and Polish pharmacy practice. Eur J Hosp Pharm. 2018:ejhpharm-2017-001432.
28.
go back to reference Christie CA, Barela E. The Delphi technique as a method for increasing inclusion in the evaluation process. Can J Program Eval. 2005;20(1):105–22. Christie CA, Barela E. The Delphi technique as a method for increasing inclusion in the evaluation process. Can J Program Eval. 2005;20(1):105–22.
29.
go back to reference Giannarou L, Zervas E. Using Delphi technique to build consensus in practice. Int J Bus Sci Appl Manag. 2014;9(2):66–82. Giannarou L, Zervas E. Using Delphi technique to build consensus in practice. Int J Bus Sci Appl Manag. 2014;9(2):66–82.
30.
go back to reference Keeney S, Hasson F, McKenna H. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs. 2006;53(1):205–12.CrossRefPubMed Keeney S, Hasson F, McKenna H. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs. 2006;53(1):205–12.CrossRefPubMed
31.
go back to reference Krzyzaniak N, Bajorek B. A global perspective of the roles of the pharmacist in the NICU. Int J Pharm Pract. 2017;25(2):107–20.CrossRefPubMed Krzyzaniak N, Bajorek B. A global perspective of the roles of the pharmacist in the NICU. Int J Pharm Pract. 2017;25(2):107–20.CrossRefPubMed
34.
go back to reference Folli HL, Poole RL, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics. 1987;79(5):718–22.PubMed Folli HL, Poole RL, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics. 1987;79(5):718–22.PubMed
35.
go back to reference Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy service. Geneva: World Health Organization, 2011 Contract No.: 961. Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy service. Geneva: World Health Organization, 2011 Contract No.: 961.
36.
go back to reference Engels Y, Campbell S, Dautzenberg M, van den Hombergh P, Brinkmann H, Szécsényi J, et al. Developing a framework of, and quality indicators for, general practice management in Europe. Fam Pract. 2005;22(2):215–22.CrossRefPubMed Engels Y, Campbell S, Dautzenberg M, van den Hombergh P, Brinkmann H, Szécsényi J, et al. Developing a framework of, and quality indicators for, general practice management in Europe. Fam Pract. 2005;22(2):215–22.CrossRefPubMed
38.
go back to reference NICE. Specialist neonatal care quality standard. skilled and multidisciplinary staff. Manchester: NICE; 2010. NICE. Specialist neonatal care quality standard. skilled and multidisciplinary staff. Manchester: NICE; 2010.
39.
go back to reference BAPM. Service standards for hospitals providing neonatal care. Pharmacy. London: BAPM; 2010. BAPM. Service standards for hospitals providing neonatal care. Pharmacy. London: BAPM; 2010.
40.
go back to reference Roughead L, Semple S, Rosenfeld E. Literature review: medication safety in Australia. Sydney: Australian Commission on Safety and Quality in Health Care 2013. Roughead L, Semple S, Rosenfeld E. Literature review: medication safety in Australia. Sydney: Australian Commission on Safety and Quality in Health Care 2013.
42.
go back to reference Mikeal RL, Brown TR, Lazarus HL, Vinson MC. Quality of pharmaceutical care in hospitals. Am J Health Syst Pharm. 1975;32(6):567–74. Mikeal RL, Brown TR, Lazarus HL, Vinson MC. Quality of pharmaceutical care in hospitals. Am J Health Syst Pharm. 1975;32(6):567–74.
43.
go back to reference WHO. Making pregnancy safer; assessment tool for the quality of hospital care for mothers and newborn babies. Advanced newborn care (for intensive care units). Copenhagen: WHO; 2009. WHO. Making pregnancy safer; assessment tool for the quality of hospital care for mothers and newborn babies. Advanced newborn care (for intensive care units). Copenhagen: WHO; 2009.
45.
go back to reference Lucas AJ. Improving medication safety in a neonatal intensive care unit. Am J Health Syst Pharm. 2004;61(1):33–7.PubMed Lucas AJ. Improving medication safety in a neonatal intensive care unit. Am J Health Syst Pharm. 2004;61(1):33–7.PubMed
48.
go back to reference Cousins D KN, Walser S,. Pharmaceutical care: policies and practices for a safer, more responsible and cost effective health system. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council of Europe, 2012. Cousins D KN, Walser S,. Pharmaceutical care: policies and practices for a safer, more responsible and cost effective health system. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council of Europe, 2012.
49.
go back to reference Kunac DL, Reith DM. Identification of priorities for medication safety in neonatal intensive care. Drug Saf. 2005;28(3):251–61.CrossRefPubMed Kunac DL, Reith DM. Identification of priorities for medication safety in neonatal intensive care. Drug Saf. 2005;28(3):251–61.CrossRefPubMed
50.
go back to reference Chedoe I, Molendijk HA, Dittrich ST, Jansman FG, Harting JW, Brouwers JR, et al. Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety. Drug Saf. 2007;30(6):503–13.CrossRefPubMed Chedoe I, Molendijk HA, Dittrich ST, Jansman FG, Harting JW, Brouwers JR, et al. Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety. Drug Saf. 2007;30(6):503–13.CrossRefPubMed
51.
go back to reference Ng J, Harrison J. Key performance indicators for clinical pharmacy services in New Zealand public hospitals: stakeholder perspectives. J Pharm Health Serv Res. 2010;1(2):75–84.CrossRef Ng J, Harrison J. Key performance indicators for clinical pharmacy services in New Zealand public hospitals: stakeholder perspectives. J Pharm Health Serv Res. 2010;1(2):75–84.CrossRef
52.
go back to reference Patel SJ, Saiman L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Sem Perinatol. 2012;36(6):431–6.CrossRef Patel SJ, Saiman L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Sem Perinatol. 2012;36(6):431–6.CrossRef
53.
go back to reference Sharek PJ, Powers R, Koehn A, Anand KJ. Evaluation and development of potentially better practices to improve pain management of neonates. Pediatrics. 2006;118(Supplement 2):S78–86.CrossRefPubMed Sharek PJ, Powers R, Koehn A, Anand KJ. Evaluation and development of potentially better practices to improve pain management of neonates. Pediatrics. 2006;118(Supplement 2):S78–86.CrossRefPubMed
54.
go back to reference Chawla D, Suresh GK. Quality improvement in neonatal care—a new paradigm for developing countries. Indian J Pediatr. 2014;81(12):1367–72.CrossRefPubMed Chawla D, Suresh GK. Quality improvement in neonatal care—a new paradigm for developing countries. Indian J Pediatr. 2014;81(12):1367–72.CrossRefPubMed
55.
go back to reference Elverson CA, Samra HA. Overview of structure, process, and outcome indicators of quality in neonatal care. Newborn Infant Nurs Rev. 2012;12(3):154–61.CrossRef Elverson CA, Samra HA. Overview of structure, process, and outcome indicators of quality in neonatal care. Newborn Infant Nurs Rev. 2012;12(3):154–61.CrossRef
Metadata
Title
Quality pharmacy services and key performance indicators in Polish NICUs: a Delphi approach
Authors
Natalia Krzyżaniak
Iga Pawłowska
Beata Bajorek
Publication date
01-06-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 3/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0623-y

Other articles of this Issue 3/2018

International Journal of Clinical Pharmacy 3/2018 Go to the issue